Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
6,337
-10,964
-63% -$490K 0.01% 661
2026
Q1
$834K Buy
17,301
+10,301
+147% +$480K 0.01% 389
2025
Q4
$339K Buy
+7,000
New +$347K 0.01% 610
2024
Q1
Sell
-5,918
Closed -$294K 477
2023
Q4
$294K Buy
5,918
+726
+14% +$35.5K ﹤0.01% 240
2023
Q3
$278K Buy
5,192
+354
+7% +$18.9K 0.01% 276
2023
Q2
$261K Sell
4,838
-1,181
-20% -$63.5K 0.01% 277
2023
Q1
$328K Buy
+6,019
New +$293K 0.01% 246
2020
Q3
Sell
-14,900
Closed -$761K 215
2020
Q2
$761K Buy
+14,900
New +$724K 0.04% 98
2013
Q4
Sell
-34,027
Closed -$1.77M 249
2013
Q3
$1.77M Buy
+34,027
New +$1.73M 0.14% 41

Other funds holding SNY

DRW Securities's SNY Position: Q2 2026 in Review

DRW Securities reduced its Sanofi (SNY) stake by 63% in Q2 2026, selling an estimated $490K and leaving 6,337 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #661.

DRW Securities first reported a position in SNY in Q3 2013 and has held it in 9 quarters since. The position peaked at $1.77M in Q3 2013. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • DRW Securities held 6,337 shares of Sanofi worth $270K as of Q2 2026.
  • DRW Securities sold 10,964 Sanofi shares in Q2 2026, an estimated $490K.
  • Sanofi made up 0.01% of DRW Securities's portfolio in Q2 2026, its #661 holding.
  • DRW Securities first reported a position in Sanofi in Q3 2013 and has held it in 9 quarters since.
  • DRW Securities's Sanofi position peaked at $1.77M in Q3 2013.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.